Caris Life Sciences®(Caris), a leading next-generation AI TechBio company and precision medicine pioneer, performs MET ...

However, these stocks also carry high risk, as their performance is heavily reliant on innovation, clinical trial success, ...

When President Joe Biden took office, he preserved most of the tariffs Trump previously enacted against China, in addition to imposing some new restrictions. But his administratio ...

Molecular diagnostic and genetic tests have the potential to provide substantial savings by helping physicians better target the right patient with the right dose of the right drug – and by ...

A new study published in Aging Cell demonstrates that artificial intelligence can be used not just to accelerate drug ...

Ribo Life's other key drug, RBD1016, targets chronic hepatitis B and hepatitis D. The company has predicted the product will become a cornerstone therapy for hepatitis B in due course. Despite the ...

Mount Sinai researchers have found that a brain region that is implicated extensively in value-based decision-making and ...

FDA will fully integrate generative AI into all centers by June 30. OpenAI and DOGE have held meetings with the FDA on a project called "cderGPT." Don’t miss this list of 3 high-yield stocks ...

Complaints about U.S. drug prices being notoriously high, even when compared with other large and wealthy countries, have long drawn the ire of both parties, but a lasting fix has never cleared ...